[go: up one dir, main page]

ES8303426A1 - Un procedimiento para la preparacion de un compuesto de cefalosporina. - Google Patents

Un procedimiento para la preparacion de un compuesto de cefalosporina.

Info

Publication number
ES8303426A1
ES8303426A1 ES510307A ES510307A ES8303426A1 ES 8303426 A1 ES8303426 A1 ES 8303426A1 ES 510307 A ES510307 A ES 510307A ES 510307 A ES510307 A ES 510307A ES 8303426 A1 ES8303426 A1 ES 8303426A1
Authority
ES
Spain
Prior art keywords
formula
procedure
cephalosporin
preparation
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES510307A
Other languages
English (en)
Other versions
ES510307A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES8303426A1 publication Critical patent/ES8303426A1/es
Publication of ES510307A0 publication Critical patent/ES510307A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE COMPUESTOS DE CEFALOSPORINA Y DE SUS SALES FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE R PUEDE SER UNO DE VARIOS RADICALES; R ES HIDROGENO O ALQUILO C <- ; A Y A'' SON HIDROGENO, ARILO O ALQUILO C <- ; Y N VALE DE 0-3. CONSISTE EN LA REACCION DE UNA 3-YODOMETIL-CEFALOSPORINA DE FORMULA (II) CUYOS GRUPOS ACIDO Y AMINO ESTAN PROTEGIDOS, CON UN ACIDO PIRIDINHIDROXAMICO O UNO DE SUS DERIVADOS, DE FORMULA (III), EN LAS QUE TODOS LOS SIMBOLOS TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA REACCION SE LLEVA A CABO EN UN DISOLVENTE APROTICO, EN CONDICIONES ANHIDRAS. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS COMO ANTIBIOTICOS.
ES510307A 1981-03-11 1982-03-10 Un procedimiento para la preparacion de un compuesto de cefalosporina. Granted ES510307A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/242,792 US4336253A (en) 1981-03-11 1981-03-11 Cephalosporin antibiotics

Publications (2)

Publication Number Publication Date
ES8303426A1 true ES8303426A1 (es) 1983-02-01
ES510307A0 ES510307A0 (es) 1983-02-01

Family

ID=22916202

Family Applications (1)

Application Number Title Priority Date Filing Date
ES510307A Granted ES510307A0 (es) 1981-03-11 1982-03-10 Un procedimiento para la preparacion de un compuesto de cefalosporina.

Country Status (21)

Country Link
US (1) US4336253A (es)
EP (1) EP0060144A3 (es)
JP (1) JPS57165393A (es)
KR (1) KR830009119A (es)
AU (1) AU8091182A (es)
BG (1) BG36936A3 (es)
CA (1) CA1177066A (es)
CS (1) CS238620B2 (es)
DD (1) DD201599A5 (es)
DK (1) DK100982A (es)
ES (1) ES510307A0 (es)
FI (1) FI820806L (es)
GB (1) GB2094309B (es)
GR (1) GR74714B (es)
IL (1) IL65185A0 (es)
NZ (1) NZ199959A (es)
PH (1) PH17022A (es)
PL (1) PL130568B1 (es)
PT (1) PT74558B (es)
RO (1) RO82962B (es)
ZA (1) ZA821525B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443444A (en) * 1980-08-11 1984-04-17 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
US4450270A (en) * 1981-10-02 1984-05-22 Eli Lilly And Company Dioximino cephalosporin antibiotics
US4616081A (en) * 1982-07-07 1986-10-07 Asahi Kasei Kogyo Kabushiki Kaisha Cephalosporin compounds
DE3316797A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
DE3316798A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
DE3588014D1 (de) * 1984-11-23 1995-06-01 Biochemie Gmbh Verfahren zur herstellung bissilylierter 3-iodmethylcephalosporinderivaten.
US4703118A (en) * 1985-04-08 1987-10-27 Eli Lilly And Company Synthesis of 3-iodomethyl cephalosporins
US4714760A (en) * 1985-08-20 1987-12-22 Bristol-Myers Company Cephalosporin intermediates
US4749522A (en) * 1985-10-31 1988-06-07 Angio-Medical Corporation Supercritical fluid extraction of animal derived materials
US4868294A (en) * 1986-07-11 1989-09-19 Bristol-Myers Company Process for preparing cephalosporin intermediates
US7847093B2 (en) * 2003-04-16 2010-12-07 Sandoz Ag Processes for the preparations of cefepime
EP2218723A3 (en) 2003-04-16 2010-11-17 Sandoz AG Processes for the preparations of cefepime
WO2006008749A1 (en) * 2004-07-16 2006-01-26 Hetero Drugs Limited Process for preparing pure cephalosporine intermediates
PT3616695T (pt) 2011-09-09 2024-11-18 Merck Sharp & Dohme Ceftolozano/tazobactam para tratar infeções intrapulmonares
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274990A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
CN110279698B (zh) 2013-03-15 2022-10-28 默沙东有限责任公司 头孢特咯瓒抗生素组合物
ES2800603T3 (es) 2013-09-09 2021-01-04 Merck Sharp & Dohme Tratamiento de infecciones con ceftolozano/tazobactam en sujetos con insuficiencia renal
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792047A (en) * 1971-12-07 1974-02-12 Glaxo Lab Ltd N-(7,2'-thienylacetamidoceph-3-em-3-ylmethyl)-3"or 4"-n-hydroxyloweralkylcarbamoyl-pyridinium-4-carboxylates
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
JPS52125188A (en) 1976-04-14 1977-10-20 Takeda Chem Ind Ltd Cephalosporin derivatives and their preparation
GR63088B (en) * 1976-04-14 1979-08-09 Takeda Chemical Industries Ltd Preparation process of novel cephalosporins
JPS6011713B2 (ja) * 1976-09-08 1985-03-27 武田薬品工業株式会社 セフアロスポリン誘導体およびその製造法
HU184631B (en) 1978-05-26 1984-09-28 Glaxo Group Ltd Process for preparing cef-3-em-4-carboxylic acid derivatives with antiaiotic activity
GB2027692B (en) 1978-05-26 1983-02-09 Glaxo Group Ltd Cephalosporin antibiotics
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
GB2043641B (en) 1979-02-23 1983-07-20 Glaxo Group Ltd Cephalosporins
US4237128A (en) * 1979-04-12 1980-12-02 E. R. Squibb & Sons, Inc. 7-[2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1,1-dialkyl)alkoxyimino]acetamido]cephem sulfoxides

Also Published As

Publication number Publication date
KR830009119A (ko) 1983-12-17
DD201599A5 (de) 1983-07-27
JPS57165393A (en) 1982-10-12
ZA821525B (en) 1983-03-30
PT74558B (en) 1984-11-27
IL65185A0 (en) 1982-05-31
US4336253A (en) 1982-06-22
PH17022A (en) 1984-05-11
EP0060144A3 (en) 1983-09-14
PL130568B1 (en) 1984-08-31
ES510307A0 (es) 1983-02-01
PT74558A (en) 1982-04-01
FI820806A7 (fi) 1982-09-12
DK100982A (da) 1982-09-12
RO82962B (ro) 1984-01-30
GB2094309A (en) 1982-09-15
BG36936A3 (bg) 1985-02-15
FI820806L (fi) 1982-09-12
EP0060144A2 (en) 1982-09-15
RO82962A (ro) 1984-01-14
CA1177066A (en) 1984-10-30
PL235396A1 (es) 1982-09-27
CS238620B2 (en) 1985-12-16
GB2094309B (en) 1985-03-27
GR74714B (es) 1984-07-06
AU8091182A (en) 1982-09-16
NZ199959A (en) 1985-08-16

Similar Documents

Publication Publication Date Title
ES8303426A1 (es) Un procedimiento para la preparacion de un compuesto de cefalosporina.
ES8306110A1 (es) &#34;procedimiento para la preparacion de derivados de urea&#34;.
ES8400444A1 (es) Procedimiento para la preparacion de nuevos derivados de carbapenem.
ES8605791A1 (es) Un procedimiento para la preparacion de derivados de imida- zodiacepina
ES8303383A1 (es) Un procedimiento para la preparacion de derivados del 1,2,5-tiadiazol
ES8304095A1 (es) Un procedimiento para la preparacion de derivados de quinazolina.
ES8600305A1 (es) Procedimiento de preparar compuestos beta-lactamicos
ES8301925A1 (es) Un procedimiento para la obtencion de un derivado acilico sustituido del compuesto acido 1,2,3,4-tetrahidro-3-isoqui- nolein-carboxilico
ES8306155A1 (es) Un procedimiento para la produccion de nuevas cefalosporinas.
ES8704965A1 (es) Un procedimiento para la preparacion de un antibiotico de macrolida
ES8301210A1 (es) Un procedimiento para la preparacion de un derivado del indol.
ES8603497A1 (es) Procedimiento para preparar derivados de cefalosporina
ES8305681A1 (es) Procedimiento para la obtencion de fenileteres sustituidos.
ES8306750A1 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles.
ES8307824A1 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES8609193A1 (es) Procedimiento para preparar analogos de mevalonolactona y derivados de los mismos
ES8205407A1 (es) Un procedimiento de preparacion de compuestos intermedios para la produccion de picropodofilina.
ES8301883A1 (es) Procedimiento para la preparacion de derivados de ciclohexe-no
ES8401080A1 (es) Procedimiento para la obtencion de esteres del acido 7 -2-(2amino-4-tiazolil)-2-(sin)-metoxiimionoacetamido)-3-cefem-4-carboxilico.
ES8606880A1 (es) Un procedimiento para la preparacion de nuevos peptidos.
ES8304140A1 (es) Procedimiento para preparar derivados de cefalosporina.
ES8601210A1 (es) Procedimiento para la preparacion de nuevos derivados de sinergistinas
ES8602002A1 (es) Procedimiento para preparar nuevas 4-fenil-tetrahidrofurano-(2,3-c)priridinas
ES8204410A1 (es) Procedimiento de obtencion de derivados de acido fenilaceti-co
ES8307827A1 (es) &#34;procedimiento para la preparacion de tiazolo(3,2-a)pirimidinas sustituidas&#34;.